Content matching 'TiGenix'
Cell therapy weekly: FDA issues strong warning, diabetes gene therapy shows promise in mice, the Cell and Gene Therapy Catapult unveils new project and Takeda eyes an acquisition
Novadip Biosciences SA, a spinout from the University of Louvain and the Saint-Luc University Hospital, has raised €28 million in a Series A financing round to develop a therapy for bone defects that is based on adipose-derived mesenchymal stem cells.
Scientists expect to have readouts next year from cell and gene therapy trials that could show that regenerative medicine is finally gaining traction.
Latest developments compiled from 1 July until 31 August 2014